Case Studies

Excellence in early and late phase clinical trials across an expansive range of therapeutic areas.

MAC brings together a diverse set of capabilities and research experience for the benefit of pharma, biotech and CROs. Our ability to recruit participants and conduct clinical trials with expertise across an extensive range of medical conditions sets us apart from other research organisations.

Alzheimers Disease
Alzheimers Disease

Timeline Recovery: MAC was approached 12 months into the trial and recruited a significant number of patients.

Anxiety
Anxiety
Atopic Dermatitis 1
Atopic Dermatitis 1

This study ran across 4 countries (UK, Germany, Belgium and Poland). MAC randomized 49% of the patients.

Atopic Dermatitis 2
Atopic Dermatitis 2
Bulimia
Bulimia
Depression
Depression

MAC recruited more patients in this depression study that several larger countries.

Diabetes
Diabetes
Diarrhoea
Diarrhoea
Fibromyalgia
Fibromyalgia

In this study MAC randomised 67% of the total UK study population.

MCI
MCI

Timeline Recovery: The IMP was going out of date. MAC successfully delivered within timeframe (single site).

Multiple Sclerosis
Multiple Sclerosis
Osteoarthritis
Osteoarthritis
Peripheral Neuropathic Pain
Peripheral Neuropathic Pain

This complex in-patient clinical trial ran in 4 countries, but many sites did not recruit any patients.

Post Menopause Hot Flushes
Post Menopause Hot Flushes
Psoriasis
Psoriasis
Sleep
Sleep

MAC EnVision® patient engagement solutions provide access to an extensive range of therapeutic areas.